A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Lensar, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 328,345 shares of LNSR stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
328,345
Previous 314,438 4.42%
Holding current value
$1.48 Million
Previous $1.1 Million 1.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$3.25 - $5.0 $45,197 - $69,535
13,907 Added 4.42%
328,345 $1.12 Million
Q4 2023

Feb 13, 2024

BUY
$2.01 - $3.51 $10,035 - $17,525
4,993 Added 1.61%
314,438 $1.1 Million
Q3 2023

Nov 14, 2023

SELL
$3.02 - $4.45 $10,419 - $15,352
-3,450 Reduced 1.1%
309,445 $956,000
Q2 2023

Aug 11, 2023

SELL
$2.3 - $4.34 $3,909 - $7,378
-1,700 Reduced 0.54%
312,895 $1.33 Million
Q1 2023

May 12, 2023

SELL
$2.19 - $3.27 $6,132 - $9,156
-2,800 Reduced 0.88%
314,595 $783,000
Q4 2022

Feb 13, 2023

SELL
$2.7 - $4.88 $38,070 - $68,808
-14,100 Reduced 4.25%
317,395 $939,000
Q3 2022

Nov 14, 2022

SELL
$4.94 - $7.0 $97,812 - $138,600
-19,800 Reduced 5.64%
331,495 $1.84 Million
Q2 2022

Aug 12, 2022

BUY
$6.15 - $7.94 $3,075 - $3,970
500 Added 0.14%
351,295 $2.29 Million
Q1 2022

May 13, 2022

SELL
$5.8 - $8.2 $45,820 - $64,779
-7,900 Reduced 2.2%
350,795 $2.6 Million
Q4 2021

Feb 11, 2022

SELL
$5.9 - $7.84 $68,440 - $90,944
-11,600 Reduced 3.13%
358,695 $2.15 Million
Q3 2021

Nov 12, 2021

SELL
$7.5 - $8.88 $108,750 - $128,760
-14,500 Reduced 3.77%
370,295 $2.83 Million
Q2 2021

Aug 13, 2021

SELL
$6.87 - $8.66 $93,432 - $117,776
-13,600 Reduced 3.41%
384,795 $3.33 Million
Q1 2021

May 13, 2021

SELL
$6.28 - $9.56 $331,584 - $504,768
-52,800 Reduced 11.7%
398,395 $2.89 Million
Q4 2020

Feb 10, 2021

BUY
$6.7 - $12.2 $3.02 Million - $5.5 Million
451,195 New
451,195 $3.27 Million

Others Institutions Holding LNSR

About LENSAR, Inc.


  • Ticker LNSR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 11,021,000
  • Market Cap $49.6M
  • Description
  • LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in...
More about LNSR
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.